MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Quantitative gait analysis to evaluate changes in gait pattern after Botulinum toxin A injection by hemiparesis

    M. Pinter, M. Petrovicsova, Y. Teuschl, A. Dachenhausen, K. Matz, C. Bancher (Krems, Austria)

    Objective: This retrospective study aimed to assess the effect of Botulinum toxin A (BoNT-A) injections in the lower limbs of hemiparetic patients on gait parameters,…
  • 2023 International Congress

    Stability of beta oscillations during aDBS in Parkinson’s disease: a methodology for reliable assessment

    S. Marceglia, A. Caruso, M. Prenassi, M. Arlotti, T. Bocci, L. Borellini, S. Pastore (Trieste, Italy)

    Objective: In this work, we describe a methodology to assess whether a specific oscillation, considered as biomarker for adaptive DBS (aDBS), is stabilized during stimulation,…
  • 2023 International Congress

    Late onset cerebellar ataxia in patients treated with VIM DBS

    C. Héraud, C. Alecu, D. Fontaine, A. Leplus, C. Giordana (NICE, France)

    Objective: To highlight the predictors for onset of cerebellar ataxia in patients treated with deep brain stimulation (DBS) of the Thalamic Ventral Intermediate Nucleus (VIM)…
  • 2023 International Congress

    Parkinson’s Disease Hospital Optimization Project

    B. Valdovinos, K. Amodeo, E. Kanouse, A. Chesire, J. Lowell, M. Braun, N. Chunga, D. Ruebeck, A. Macikowski, V. Basic, M. Deweese, E. Hufziger, J. Hayes, A. Skuse, I. Richard (Rochester, USA)

    Objective: To describe The Parkinson’s Disease Hospital Optimization Project (PD-HOP) that we established to optimize inpatient care and improve the hospital experience and outcomes for…
  • 2023 International Congress

    Alterations of gait as an early marker of incipient alpha-synucleinopathy

    K-L. Weiß, S. Röttgen, A. Ophey, G. Fink, M. Sommerauer (Cologne, Germany)

    Objective: To investigate early motor signs of α-synucleinopathies in patients with isolated REM sleep behavior disorder (iRBD) using gait analysis. Background: iRBD is an early…
  • 2023 International Congress

    RNA editing contributes to the inflammatory astrocytic response in Parkinson’s disease.

    A. Wagen, K. D'Sa, M. Choi, S. Strohbuecker, G. Young, R. Reynolds, S. Garcia-Ruiz, Z. Chen, A. Ghareeb, J. Bayne, S. Rodriques, M. Horrocks, S. Gandhi, M. Ryten (London, United Kingdom)

    Objective: 1) Using an IPSC derived cell model to explore astrocytic responses alone and cocultured neurons to alpha-synuclein oligomer (αsynO) treatment.2) Determine the extent to…
  • 2023 International Congress

    Exome sequencing of 584 Chinese proband with brain calcification

    ZR. Lin (Hangzhou, China)

    Objective: The aim of this study is to evaluate the diagnostic value of whole exome sequencing in Chinese patients with brain calcification, and to provide exome sequencing-based insights into the genetic…
  • 2023 International Congress

    Anodal Transcranial Direct Current Stimulation (tDCS) on sensorimotor cortex in patients with early-onset Parkinson’s Disease: a Pilot Study.

    C. Simonetta, J. Bissacco, M. Conti, V. Ferrari, M. Pierantozzi, C. Salimei, A. Stefani, NB. Mercuri, T. Schirinzi (Roma, Italy)

    Objective: To evaluate the clinical effects of anodal Transcranial Direct Current Stimulation (tDCS) application on sensorimotor cortex in a group of early-onset Parkinson’s Disease patients.…
  • 2023 International Congress

    Case Study: Pitfalls of Commercial Genetic Testing for Huntington’s Disease

    L. Fanty, J. Bravo, S. Corrigan, M. Maczis, L. Kugelmann, A. Wagle Shukla, M. Farrer, N. Mcfarland (Gainesville, USA)

    Objective: We present a family with initial false negative commercial testing for Huntington Disease (HD) and subsequent whole genome sequencing (WGS) that revealed an expanded…
  • 2023 International Congress

    Mitochondrial DNA copy number is associated with the severity of motor symptoms and dementia in Parkinson’s disease

    S. Jo, JH. Oh, S. Lee, J. Lee, CO. Sung, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the diagnostic and prognostic role of blood mitochondrial DNA copy number (mtDNA-CN) measured by whole genome sequencing (WGS) in relation…
  • « Previous Page
  • 1
  • …
  • 428
  • 429
  • 430
  • 431
  • 432
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley